Ensure absolute sterility, seal strength, and long-term shelf-life stability for medical devices and pharmaceuticals. Proven scientific validation protocols executed in our ISO 13485:2016 and MDSAP certified Texas laboratory facilities.
For global medical device procurement directors, regulatory managers, and quality assurance engineers, Packaging Integrity Testing is far more than a routine compliance checkpoint—it is the definitive scientific line of defense protecting patient safety and securing product market authorization.
A Sterile Barrier System (SBS) must maintain sterility throughout its specified shelf-life, withstand the mechanical stress of transit, and endure sterilization modalities such as Ethylene Oxide (EO), E-Beam, or Steam without compromising its physical or microbial barrier. Under global regulatory frameworks—including the European Union Medical Device Regulation (EU MDR 2017/745), U.S. FDA 21 CFR Part 820, and ISO 11607-1/2—manufacturers must provide robust, reproducible, and scientifically validated data demonstrating that their primary packaging maintains sterile integrity from production to the point of clinical use.
Information Gain Insight: Modern semantic search and regulatory audits require a dual approach to packaging validation: physical seal integrity testing combined with microbial barrier verification and environmental durability studies. C.G. Laboratories delivers deterministic and probabilistic testing regimes engineered to eliminate false positives and ensure seamless regulatory submissions.
When sourcing packaging validation services, global buyers often confront complex technical trade-offs between porous materials (such as Tyvek® bonded to flexible films) and non-porous barriers (foil laminates or rigid thermoformed trays). Each material combination presents unique failure mechanisms, including channel leaks, seal creep, pinhole formation, and adhesive delamination. C.G. Laboratories brings over 40 years of continuous laboratory experience to analyze these risk vectors, optimizing test protocols tailored precisely to your packaging geometry and distribution profile.
To establish full compliance with ISO 11607-1 (Packaging for terminally sterilized medical devices), C.G. Laboratories offers a comprehensive suite of physical integrity, seal strength, leak detection, and shelf-life aging tests. Below are our key standardized testing methodologies recommended for global medical device procurement:
Measures the maximum force required to separate heat-sealed flexible packaging materials. We evaluate seal uniformity, peel characteristics, and failure modes (peel vs. tear vs. delamination) using precision tensile testing machinery.
Explore Contract PackagingDetects channel leaks as small as 50 µm along the seal boundary of porous packaging materials (Tyvek/plastic pouches). Using colored dye solutions applied via capillary injection, channels are rapidly identified under magnification.
Explore Lab TestingStandard test method for detecting gross leaks in packaging by internal pressurization (Bubble Test). Submerges packages underwater while applying controlled pressure differential to reveal micro-voids across porous and non-porous barriers.
Sterilization SupportSimulates real-time aging through elevated temperature and humidity conditioning (utilizing the Arrhenius Q10 reaction rate function). Validates package integrity and seal retention across 1-year, 3-year, or 5-year equivalent timelines.
Environmental Aging EquipmentSubjecting shipping containers and primary packages to drop, drop impact, random vibration, vehicle simulation, and atmospheric pressure changes to ensure the sterile barrier remains intact throughout global logistics chains.
Validation StrategyNon-destructive deterministic leak test solutions—such as vacuum decay and mass extraction—offering quantifiable leak rate measurements for ultra-sensitive medical devices, implants, and hydrogel packaging.
Hydrogel Packaging ServicesDifferent packaging configurations require tailored analytical standards. The comparative matrix below outlines key parameters evaluated by our scientific team during protocol selection:
| Test Standard | Methodology Type | Primary Application | Detectability Limit | ISO 11607 Relevance |
|---|---|---|---|---|
| ASTM F88 / F88M | Physical Destructive (Tensile) | Pouch & Tray Heat Seal Strength | Force measurement (N/m or lbf/in) | Mandatory for seal integrity characterization |
| ASTM F1929 | Visual / Chemical Penetration | Porous package seal channels | 50 µm channels | Standard method for Tyvek® pouch seals |
| ASTM F2096 | Internal Air Pressurization | Gross leak detection (Porous/Non-Porous) | 250 µm defects | Rapid package failure screening |
| ASTM F1980 | Climatic Conditioning | Accelerated & Real-Time Aging | Time-temperature degradation kinetics | Required for product shelf-life claim verification |
| ASTM F2338 | Deterministic Vacuum Decay | Non-destructive micro-leak testing | Up to 5–10 µm micro-leaks | USP <1207> aligned high-sensitivity validation |
As global supply chains become more sophisticated and regulatory scrutiny intensifies, procurement teams must anticipate shifts in packaging science. The next 5–10 years will redefine how sterile packaging is designed, validated, and monitored.
Regulatory authorities (including US FDA and EU Notified Bodies) are increasingly favoring non-destructive, deterministic test methods over probabilistic visual methods (such as traditional bubble testing). Methods like vacuum decay (ASTM F2338) and mass extraction provide definitive quantitative leak rates, eliminating operator subjectivity and enabling 100% batch inspection options for high-value surgical implants.
Environmental directives in Europe and North America are driving the development of mono-material recyclable films and bio-based polymers for medical pouches. Sourcing teams must rigorously evaluate seal stability, tensile strength retention post-EO/E-Beam sterilization, and resistance to environmental stress cracking under accelerated aging protocols.
With the adoption of the Medical Device Single Audit Program (MDSAP) across Canada, the U.S., Japan, Brazil, and Australia, procurement departments are seeking centralized laboratory partners capable of delivering validation packages that fulfill ISO 11607, ASTM, and regional pharmacopeial standards simultaneously.
Novel therapeutic medical devices—such as advanced wound care dressings, bioactive hydrogels, and wearable electronic biosensors—introduce moisture sensitivity and chemical interaction challenges. Packaging integrity testing for hydrogels requires precise atmospheric control and specialized seal validation to prevent moisture loss or migration.
Selecting a laboratory partner for packaging integrity testing requires absolute trust in scientific accuracy, quality systems, and communication speed. Founded in 1983 by Dr. Glenn Crum, C.G. Laboratories has established a 40+ year legacy of excellence as a trusted partner to medical device manufacturers worldwide.
Our quality management system is fully certified to ISO 13485:2016, MDSAP, and CLIA, and registered with the FDA. Your audit documentation is fully compliant out of the box.
Operating across two dedicated sites in Granbury, Texas, our extensive laboratory infrastructure features advanced environmental aging chambers, tensile test stations, cleanroom environments, and contract packaging lines.
We do not route your technical queries through automated portals. Our senior scientists—with over 90 years of combined laboratory experience—work with you directly from protocol formulation to final report sign-off.
Beyond packaging testing, we offer seamless contract packaging, hydrogel packaging, sterilization validation (EO, Steam, E-Beam), and decontamination services with a proven 72-hour operational TAT objective.
Below are expert scientific answers to the most frequent queries raised by global procurement specialists and quality management teams regarding packaging integrity testing:
Sample sizes for ISO 11607 validation are based on statistical risk analysis using Acceptable Quality Limit (AQL) standards, variable vs. attribute data, and confidence/reliability intervals (typically 95% Confidence / 95% Reliability for high-risk medical devices). For seal strength testing (ASTM F88), variable quantitative data is collected, allowing smaller sample sizes (e.g., 30 samples per lot across 3 independent production runs). For attribute pass/fail tests like dye penetration (ASTM F1929), larger sample sizes may be required. C.G. Laboratories assists clients in calculating statistically defensible sample sizes tailored to your device risk class.
Seal Strength Testing (e.g., ASTM F88) evaluates the mechanical force required to pull a heat seal apart, measuring the physical bond integrity and process consistency of your sealing equipment. It ensures the package will not burst during handling or pressure differentials. Package Integrity Leak Testing (e.g., ASTM F1929 dye penetration, ASTM F2096 bubble leak, ASTM F2338 vacuum decay) verifies the continuous sterile barrier by detecting physical micro-channel defects, pinholes, or voids that could allow microbial ingress. Both tests are required under ISO 11607 to prove complete sterile barrier compliance.
Sterilization processes exert physical and chemical stress on packaging materials. Ethylene Oxide (EO) sterilization involves vacuum pulses, elevated temperature, humidity, and gas pressure changes, which can induce seal creep or package stress if ventilation (porosity) is inadequate. E-Beam and Gamma radiation can cause polymer cross-linking or chain scission, embrittling film layers and degrading seal strength over time. C.G. Laboratories performs comparative pre- and post-sterilization packaging integrity testing to confirm your packaging maintains structural and barrier properties after exposure to maximum sterilization doses.
Accelerated aging subjects packages to elevated temperatures (e.g., 50°C to 60°C) to artificially speed up the chemical degradation of packaging materials, allowing rapid market launch while real-time aging studies run concurrently. Aging factors are derived from the Arrhenius reaction rate equation using a standard Q10 temperature coefficient of 2.0. For example, testing at 55°C can simulate 1 year of ambient shelf life in approximately 40 days. Our environmental aging facility in Granbury, TX is equipped with continuous monitoring to execute custom accelerated shelf-life protocols.
Yes. C.G. Laboratories offers a fully integrated, turn-key solution. We provide contract packaging, hydrogel formulation and packaging, heat sealing validation, sterilization validation, environmental monitoring, and comprehensive ISO 11607 packaging integrity testing under one unified ISO 13485 quality umbrella. This eliminates vendor fragmentation, reduces transit risks between suppliers, and accelerates total turnaround time to commercial distribution.
Clients receive a comprehensive, audit-ready Validation Final Report containing complete protocol specifications, calibrated equipment tracking numbers, raw tensile force curves, micro-leak observation logs, statistical analysis (mean, standard deviation, confidence limits), and signed scientific conclusions confirming ISO 11607 compliance for submission to FDA, EU Notified Bodies, or MDSAP auditors.
Put over 40 years of medical device microbiological and packaging validation expertise to work for your enterprise. Our scientists are standing by to review your device specifications and build a custom validation protocol.
